Home » Topics » Science » Biomarkers

Biomarkers
RSS

Serum PRO-C6 monitors and predicts infliximab response in patients with Crohn's disease

Feb. 14, 2022

CK-BB predicts never awakening in patients treated with hypothermia after cardiac arrest

Feb. 11, 2022

IFI27L2A and IFITM3 increase their expression after stroke

Feb. 11, 2022

Investigators find a role for miR-206 in intracerebral hemorrhage

Feb. 10, 2022

Researchers unveil new miRNAs tied to cerebral cavernous angioma

Feb. 10, 2022

Fibrinogen as marker of joint health in patients with severe hemophilia

Feb. 7, 2022

ETV6 and FYB1 rare genetic mutations tied to inherited thrombocytopenia

Feb. 7, 2022

Novel mutations in the FGG gene tied to thrombosis and dysfibrinogenemia

Feb. 7, 2022

Loss of miR-15a/miR-16-1 contributes to CLL development

Feb. 1, 2022

STK26 and DPP4 identified as markers tied to severe COVID-19 risk

Jan. 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...